You are here: Industry Insights > Arthritis

News List

Healthy Lifestyle Cuts Rheumatoid Arthritis Risk drugs.com
February 07, 2022
A healthier lifestyle is associated with lower rheumatoid arthritis (RA) risk, according to a study published online Jan. 18 in Arthritis Care & Research.
AHA News: He Got Help F.A.S.T. For His Stroke. His Mother Wasn't as Lucky. drugs
August 27, 2021
It was the evening of Jan. 30, 2007, when Mike Maddux got the phone call from his stepfather.
Anifrolumab Shows Benefit in Patients with Systemic Lupus Erythematosus americanpharmaceuticalreview
June 04, 2021
A new post-hoc analysis of pooled data from the TULIP Phase III clinical trials being presented at the annual European Congress of Rheumatology (EULAR 2021) showed anifrolumab was consistently associated with improvements in both skin rash and ...
Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients worldpharmanews
March 01, 2021
Treating critically ill COVID-19 patients with drugs typically used for rheumatoid arthritis may significantly improve survival, a landmark study has found.
Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership prnasia
January 11, 2021
Standigm Inc. announced that they had successfully found a new arthritis indication for an FDA-approved drug and filed a patent. This is the first successful result of their open innovation partnership, formed in July 2019.
Pfizer get USFDA nod for XELJANZ (tofacitinib) to treat active polyarticular course juvenile idiopathic arthritis expresspharma
October 09, 2020
Two formulations were approved, a tablet and an oral solution, and are dosed based upon weight.
First UK patient given GSK’s experimental arthritis drug in COVID-19 trial pharmatimes
September 30, 2020
A patient in Manchester is the first in the UK to be treated in a new COVID-19 trial investigating the use of an experimental arthritis drug, otilimab, for severe lung disease related to the novel coronavirus.
Researchers investigate impact of lockdown on musculoskeletal conditions pharmatimes
May 27, 2020
Researchers at the University of Aberdeen have been awarded £52,000 to investigate the impact of lockdown on patients with arthritis and other musculoskeletal conditions.
Scorpion-derived proteins deliver steroids to combat arthritis in rats europeanpharmaceuticalreview
March 10, 2020
Researchers have identified a tiny protein in scorpion venom that rapidly accumulates in joint cartilage to deliver arthritis drugs in a pre-clinical study.
Mental Distress, Depression Prevalent in Adults With Arthritis drugs
January 03, 2020
The prevalence of mental distress is 16.8 percent and the prevalence of depression is 32.1 percent among adults with arthritis ...

Previous page 1 2 3 4 Next page